Literature DB >> 23979745

Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae.

Masayuki Nigo1, Catalina Salinas Cevallos, Krystina Woods, Vicente Maco Flores, Gweneth Francis, David C Perlman, Manuel Revuelta, Donna Mildvan, Mary Waldron, Tessa Gomez, Sanjana Koshy, Tomasz Jodlowski, William Riley, Jörg J Ruhe.   

Abstract

We performed a nested case-control study (ratio of 1:4) on the emergence of tigecycline-resistant multidrug-resistant Klebsiella pneumoniae (TR-MDRKP) isolates among patients who initially presented with a tigecycline-susceptible MDRKP isolate. Out of 260 patients, 24 (9%) had a subsequent clinical culture positive for a TR-MDRKP isolate within the 90-day follow-up period. On logistic regression analyses, receipt of tigecycline (adjusted odds ratio [OR], 5.06; 95% confidence interval [CI], 1.80 to 14.23; P = 0.002) was the only independent predictor of subsequent isolation of a TR strain.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23979745      PMCID： PMC3811295          DOI： 10.1128/AAC.00827-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Emergence of tigecycline resistance amongst multi-drug resistant gram negative isolates in a multi-disciplinary hospital.

Authors:  Subhash C Arya; Nirmala Agarwal
Journal:  J Infect       Date:  2010-07-27       Impact factor: 6.072

2.  First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital.

Authors:  I K Neonakis; K Stylianou; E Daphnis; S Maraki
Journal:  Indian J Med Microbiol       Date:  2011 Jan-Mar       Impact factor: 0.985

3.  Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant patient.

Authors:  C Rodríguez-Avial; I Rodríguez-Avial; P Merino; J J Picazo
Journal:  Clin Microbiol Infect       Date:  2011-07-01       Impact factor: 8.067

4.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 5.  Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.

Authors:  Neil Gupta; Brandi M Limbago; Jean B Patel; Alexander J Kallen
Journal:  Clin Infect Dis       Date:  2011-07-01       Impact factor: 9.079

6.  Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.

Authors:  Michael J Satlin; Christine J Kubin; Jill S Blumenthal; Andrew B Cohen; E Yoko Furuya; Stephen J Wilson; Stephen G Jenkins; David P Calfee
Journal:  Antimicrob Agents Chemother       Date:  2011-10-03       Impact factor: 5.191

Review 7.  Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies.

Authors:  Theodoros Kelesidis; Drosos E Karageorgopoulos; Iosif Kelesidis; Matthew E Falagas
Journal:  J Antimicrob Chemother       Date:  2008-08-01       Impact factor: 5.790

8.  Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.

Authors:  Nada S Al-Qadheeb; Sahar Althawadi; Abdulaziz Alkhalaf; Suleiman Hosaini; Abdulrahman A Alrajhi
Journal:  Ann Saudi Med       Date:  2010 Sep-Oct       Impact factor: 1.526

Review 9.  The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.

Authors:  Patrice Nordmann; Gaelle Cuzon; Thierry Naas
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

10.  Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors:  K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948
View more
  15 in total

1.  Tigecycline resistance among Klebsiella pneumoniae isolated from febrile neutropenic patients.

Authors:  Sherein G Elgendy; Muhammad R Abdel Hameed; Mohamed A El-Mokhtar
Journal:  J Med Microbiol       Date:  2018-05-25       Impact factor: 2.472

2.  Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  David van Duin; Eric Cober; Sandra S Richter; Federico Perez; Robert C Kalayjian; Robert A Salata; Scott Evans; Vance G Fowler; Robert A Bonomo; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-20       Impact factor: 3.254

Review 3.  Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria.

Authors:  Neelam Taneja; Harsimran Kaur
Journal:  Microbiol Insights       Date:  2016-03-20

Review 4.  Tetracycline Antibiotics and Resistance.

Authors:  Trudy H Grossman
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

5.  Mutant prevention concentration of tigecycline for clinical isolates of Streptococcus pneumoniae and Staphylococcus aureus.

Authors:  C K Hesje; K Drlica; J M Blondeau
Journal:  J Antimicrob Chemother       Date:  2014-10-16       Impact factor: 5.790

6.  Risk Factors, Outcomes, and Mechanisms of Tigecycline-Nonsusceptible Klebsiella pneumoniae Bacteremia.

Authors:  Chih-Han Juan; Yi-Wei Huang; Yi-Tsung Lin; Tsuey-Ching Yang; Fu-Der Wang
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.

Authors:  D van Duin; E D Cober; S S Richter; F Perez; M Cline; K S Kaye; R C Kalayjian; R A Salata; S R Evans; V G Fowler; R A Bonomo
Journal:  Clin Microbiol Infect       Date:  2014-12-12       Impact factor: 8.067

8.  The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients.

Authors:  M Papadimitriou-Olivgeris; M Christofidou; F Fligou; C Bartzavali; T Vrettos; K S Filos; M Marangos; E D Anastassiou
Journal:  Infection       Date:  2014-07-10       Impact factor: 3.553

9.  Clinical and microbiological characteristics of tigecycline non-susceptible Klebsiella pneumoniae bacteremia in Taiwan.

Authors:  Yi-Tsung Lin; Fu-Der Wang; Yu-Jiun Chan; Yung-Chieh Fu; Chang-Phone Fung
Journal:  BMC Infect Dis       Date:  2014-01-01       Impact factor: 3.090

10.  Genome sequencing and genomic characterization of a tigecycline-resistant Klebsiella pneumoniae strain isolated from the bile samples of a cholangiocarcinoma patient.

Authors:  Beiwen Zheng; Ang Li; Xiawei Jiang; Xinjun Hu; Jian Yao; Lina Zhao; Jinru Ji; Min Ye; Yonghong Xiao; Lanjuan Li
Journal:  Gut Pathog       Date:  2014-09-27       Impact factor: 4.181
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.